SpaceX Investors, Mark Your Calendars: A Massive Stock Lockup Expiration Is Coming

Two trading days after SpaceX’s Oct. 20 third-quarter update, 1.3 billion shares are scheduled to become eligible for sale, with another 328 million unlocking on Oct. 24. Past lockup expirations have produced mixed stock reactions, and the company’s shares have risen about 27% since Aug. 6; third-quarter results could offset some selling pressure. The article cites a valuation of 200x forward earnings and recommends avoiding the stock at current levels despite recent business progress.

Analysis

The key distinction is eligibility versus actual selling: an unlock creates potential supply, not a mechanically fixed sell order. The near-term risk is therefore a change in marginal price-setting—especially if buyers require a discount to absorb insider sales—not the headline share count alone. Past unlock reactions are weak evidence because market depth, seller behavior, and expectations differ across dates.

In the next few sessions, the earnings update and post-unlock trading should be read together. Revenue quality, cash conversion, spending needs, and any guidance on Starship or connectivity matter more than headline growth; strong results can still fail to support the stock if they do not improve the path to durable cash generation. Over 1–3 months, monitor actual shares entering public float, insider-sale filings, turnover, and whether price stabilizes without unusually high volume. Over 6–18 months, execution and capital demands determine whether the equity’s strategic optionality translates into per-share value; a persistent overhang could also weaken the stock’s usefulness as employee compensation or acquisition currency.

Contrarian point: the unlock may be overemphasized if the market has already discounted likely sales and buyers absorb supply. Conversely, calling the event benign based on prior dates ignores that seller mix and float absorption can change. Listed space and satellite-connectivity names such as Rocket Lab, AST SpaceMobile, and Iridium are not clean hedges for SpaceX; their own company-specific drivers dominate. No valuation conclusion is reliable without checking the forward-earnings assumptions and share-count basis cited in the article.

Key Decisions for Investors

• Avoid initiating an outright short solely on the unlock. Treat it as a supply-risk event, and wait for post-event volume, filings, and price behavior before adding exposure.
• For existing SPCX holders, consider a temporary, defined-risk hedge only if options are liquid and implied volatility does not make protection prohibitively expensive; otherwise reduce exposure to a level that can tolerate a further drawdown.
• Watch for confirmation over the next 1–3 months: disclosed insider sales, float growth, unusually heavy turnover, and failure to hold the post-update range. A firm price on elevated volume with limited disclosed selling would weaken the overhang thesis.
• Reassess on operating evidence, not promotional milestones alone: verify segment revenue, cash conversion, capital spending, and guidance. Deteriorating cash generation or delayed execution would falsify the view that strong strategic prospects can offset supply pressure.